TSE:CRH - CRH Medical Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
C$3.52 +0.01 (+0.28 %)
(As of 03/26/2019 04:00 PM ET)
Previous CloseC$3.51
Today's RangeC$3.49 - C$3.57
52-Week RangeC$3.09 - C$5.91
Volume104,090 shs
Average Volume138,816 shs
Market CapitalizationC$252.43 million
P/E Ratio55.87
Dividend YieldN/A
BetaN/A
CRH Medical Corporation provides various products and services to gastroenterologists for the treatment of gastrointestinal diseases in the United States, Canada, and internationally. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid. The company also offers anesthesia services for patients undergoing endoscopic procedures. It distributes the CRH O'Regan system, treatment protocols, and operational and marketing expertise as a turnkey package directly to gastroenterology practices. The company was formerly known as Medsurge Medical Products Corp. and changed its name to CRH Medical Corporation in April 2006. CRH Medical Corporation was founded in 2000 and is headquartered in Vancouver, Canada.

Receive CRH News and Ratings via Email

Sign-up to receive the latest news and ratings for CRH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-604-6331440

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$112.75 million
Cash FlowC$0.13 per share
Book ValueC$1.08 per share

Profitability

Miscellaneous

EmployeesN/A
Market CapC$252.43 million
Next Earnings Date4/29/2019 (Estimated)
OptionableOptionable

CRH Medical (TSE:CRH) Frequently Asked Questions

What is CRH Medical's stock symbol?

CRH Medical trades on the Toronto Stock Exchange (TSX) under the ticker symbol "CRH."

How were CRH Medical's earnings last quarter?

CRH Medical Corp (TSE:CRH) posted its earnings results on Wednesday, March, 13th. The company reported $0.03 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.03. The firm had revenue of $42.33 million for the quarter, compared to analysts' expectations of $41.45 million. View CRH Medical's Earnings History.

When is CRH Medical's next earnings date?

CRH Medical is scheduled to release their next quarterly earnings announcement on Monday, April 29th 2019. View Earnings Estimates for CRH Medical.

What price target have analysts set for CRH?

4 brokerages have issued 12 month target prices for CRH Medical's shares. Their forecasts range from C$5.50 to C$6.00. On average, they expect CRH Medical's share price to reach C$5.69 in the next year. This suggests a possible upside of 61.6% from the stock's current price. View Analyst Price Targets for CRH Medical.

What is the consensus analysts' recommendation for CRH Medical?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CRH Medical in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CRH Medical.

Has CRH Medical been receiving favorable news coverage?

Headlines about CRH stock have been trending negative on Tuesday, InfoTrie Sentiment reports. The research group rates the sentiment of press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. CRH Medical earned a media sentiment score of -2.1 on InfoTrie's scale. They also gave news stories about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the company's share price in the immediate future.

Who are some of CRH Medical's key competitors?

What other stocks do shareholders of CRH Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CRH Medical investors own include CRH Medical (CRHM), Trican Well Service (TCW), Dollarama (DOL), Aurora Cannabis (ACB), ProMetic Life Sciences (PLI), Alimentation Couche-Tard (ATD.B), Journey Energy (JOY), DHX Media (DHX.B), Toronto-Dominion Bank (TD) and NVIDIA (NVDA).

Who are CRH Medical's key executives?

CRH Medical's management team includes the folowing people:
  • Mr. Edward Wright, CEO & Non-Independent Director (Age 56)
  • Mr. Richard K. Bear, CFO & Corp. Sec. (Age 56)
  • Mr. James Kreger, Pres of CRH Anesthesia Management
  • Ms. Kettina Cordero, Director of Investor Relations

How do I buy shares of CRH Medical?

Shares of CRH and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is CRH Medical's stock price today?

One share of CRH stock can currently be purchased for approximately C$3.52.

How big of a company is CRH Medical?

CRH Medical has a market capitalization of C$252.43 million and generates C$112.75 million in revenue each year.

What is CRH Medical's official website?

The official website for CRH Medical is http://investors.crhsystem.com/.

How can I contact CRH Medical?

CRH Medical's mailing address is 57B - 999 Canada Place World Trade Center, VANCOUVER, BC V6C 3E1, Canada. The company can be reached via phone at +1-604-6331440.


MarketBeat Community Rating for CRH Medical (TSE CRH)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  172 (Vote Outperform)
Underperform Votes:  186 (Vote Underperform)
Total Votes:  358
MarketBeat's community ratings are surveys of what our community members think about CRH Medical and other stocks. Vote "Outperform" if you believe CRH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CRH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/26/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel